Evogene Ltd. | CIK:0001574565 | 3

  • Filed: 3/30/2018
  • Entity registrant name: Evogene Ltd. (CIK: 0001574565)
  • Generator: GoXBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/0001178913-18-001042-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1574565/000117891318001042/evgn-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001574565
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory

    NOTE 17: -    SHAREHOLDERS' EQUITY

    a.
    General:

    All ordinary shares, options, per share data and exercise prices included in these financial statements for all periods presented have been adjusted to reflect the 1-for-2 reverse share split effected on November 19, 2013.

    b.
    Share capital:
     
       
    December 31,
    		  
       
    2017
    		    
    2016
    		  
       
    Authorized
    		    
    Issued and Outstanding
    		    
    Authorized
    		    
    Issued and Outstanding
    		  
       
    Number of shares
    		  
    Ordinary shares of NIS 0.02 par value each
    		    
    150,000,000
    		      
    25,750,547
    		      
    150,000,000
    		      
    25,480,809
    		  
     
    c.
    Changes in share capital:

    Share capital issued and outstanding:
     
       
    Number of shares
    		    
    NIS par value
    		  
    Outstanding at January 1, 2016
    		    
    25,404,362
    		      
    508,087
    		  
                     
    Exercise of options
    		    
    76,447
    		      
    1,529
    		  
                     
    Outstanding at December 31, 2016
    		    
    25,480,809
    		      
    509,616
    		  
                     
    Exercise of options
    		    
    269,738
    		      
    5,395
    		  
                     
    Outstanding at December 31, 2017
    		    
    25,750,547
    		      
    515,011
    		  
     
    d.
    Rights attached to shares:

      Voting rights at the general meeting, rights to dividends, rights upon liquidation of the Company and the right to appoint directors of the Company.

    e.
    Capital management in the Company:

    The Company's objectives in managing capital are as follows:

    To maintain its ability to ensure the continuity of the business, and thus to generate a return to equity holders, investors and other parties.

    The Company manages its capital structure and makes adjustments following changes in economic conditions and the risk-nature of its operations. In order to maintain or to adjust the necessary capital structure, the Company takes various steps, such as raising funds by capital issues.